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Uncoupling protein (UCP) is a mitochondrial membrane protein that uncouples oxidative phosphorylation. The
physiological function of major isoforms of UCPs is related to the control of body temperature and reactive
oxygen species production. Although skin is an important organ for heat radiation and protection against stress,
the expression and function of UCPs in the skin have remained unclear. The expression of UCPs in human skin
and its derived cells was researched at the mRNA and protein levels. The effects of norepinephrine (NE) and
9-cis retinoic acid (RA) on UCP expression were also investigated. The expression of UCP1 mRNA was found in
the human epidermis and was upregulated in differentiated keratinocytes. UCP1 expression in keratinocytes
was synergistically upregulated by NE and RA treatment. Significant expression of UCP2 and UCP3 was observed
also in cultured keratinocytes and fibroblasts. By immunohistochemistry, localization of UCP1 was found in the
granular layer of the epidermis, sweat glands, hair follicles, and sebaceous glands of various sites in the human
body. UCP3 was widely found in the dermis. This showed that UCPs exist in human skin, with their expression
being under hormonal control. These findings are in stark contrast with the well-accepted view of UCP1
expression being exclusive to brown adipose tissue.
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INTRODUCTION
Uncoupling protein (UCP), as the name suggests, is a
molecule that uncouples mitochondrial oxidative phosphor-
ylation by bypassing the electrochemical gradient across the
inner membrane from the F1-ATPase, thereby dissipating
energy as heat (Jezek, 1999). Among the several isoforms of
the UCP family reported so far (Ricquier and Bouillaud,
2000), UCP1 is expressed exclusively in brown adipose tissue
(BAT), which is the major site of regulatory thermogenesis in
small rodents during cold acclimation, arousal from hiberna-
tion, and recovery from anesthetic hyperthermia (Shimizu
and Saito, 1991). Since UCP1 is also activated during
voluntary overfeeding, this isoform is believed to be a key
molecule in diet-induced thermogenesis as well as cold-
induced thermogenesis and thereby in the autonomic control
of energy expenditure and whole-body energy balance
(Cannon et al., 1982; Nedergaard and Cannon, 1985; Klaus
et al., 1998; Baumruk et al., 1999). However, unlike small
rodents, larger mammals, including humans, have only
minute amounts of BAT, and the physiological significance
of UCP1 in these species has been debatable. In contrast to
UCP1, UCP2 is expressed ubiquitously in various tissues, and
UCP3 is expressed abundantly in the skeletal muscle and
BAT. Two forms of UCP3 are found in human tissue, the long
form (UCP3L) and the short form (UCP3S). They are produced
from the same gene by alternative splicing (Boss et al., 1997;
Fleury et al., 1997; Solanes et al., 1997). Since these UCP
isoforms have uncoupling activity when expressed in yeast,
they have been suggested to be involved in the regulation of
energy expenditure. UCPs have also been suggested to play a
role in diminishing reactive oxygen species (Nagase et al.,
1994, 2001; Tsukazaki et al., 1995; Boss et al., 1998; Hinz
et al., 1999; Clapham et al., 2000; Vidal-Puig et al., 1997,
2000).
The mammalian skin is a critical site for regulating
the entry and release of heat, and acts as a barrier
against water and other substances. Heat produced in the
body is dispersed from the skin surface by radiation or
perspiration, whereas subcutaneous adipose tissue under the
dermis acts as an insulator (Cassard et al., 1990; Irie et al.,
1999). Heat production and radiation via skin, including
subcutaneous tissue, are interesting with regard not only to
thermoregulation, but also to energy metabolism; however,
there have been no reports about the expression of UCPs
in the skin, except for that in subcutaneous fat tissue,
including BAT.
In this study, expression of the three UCP isoforms was
examined at the mRNA and protein levels in human skin and
skin-derived cells. The effects of norepinephrine (NE) and
retinoid treatment were also investigated.
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RESULTS
UCP mRNA in human skin-derived cells
Total RNA of fetal foreskin-derived keratinocytes and
fibroblasts, the major cell types of the epidermis and dermis,
respectively, was analyzed by reverse transcriptase (RT)–PCR
(Figure 1). UCP1 mRNA was detected in primary cultured
keratinocytes but not in fibroblasts. The mRNA of UCP2,
UCP3L, and UCP3S was observed in primary cultured
keratinocytes and fibroblasts at levels comparable to those
in skeletal muscle. The size of the PCR products for each
isoform of the UCPs and their nucleotide sequences were
completely identical to those for human UCPs (Moschella
et al., 1975).
UCP1, UCP2, and UCP3L expression was examined in
keratinocytes during differentiation. As shown in Figure 2a,
all UCP signals, including UCP1, were observed in keratino-
cytes during differentiation. The quantity of each UCP by
real-time PCR is shown in Figure 2b. UCP1 expression was
almost stable, but gradually increased up to 2.5-fold
depending on the differentiation time. UCP2 was upregulated
transiently but reverted to basal level. The expression of
UCP3 was stable for 8 days of differentiation. Similar UCP
expression patterns were confirmed in the other four lots of
keratinocytes derived from fetal foreskin and adult breast skin
(data not shown).
The effects of 9-cis retinoic acid (RA) and NE treatment
on UCP1 expression were investigated and quantified by
RT–PCR and real-time PCR (Figure 3a and b). When
keratinocytes were treated with 1 mM RA for 24 hours, UCP1
mRNA expression increased about 2.6-fold. Treatment with
1 mM NE also slightly increased UCP1 mRNA levels about
1.8-fold. Moreover, co-treatment with RA and NE synergis-
tically enhanced UCP1 mRNA levels about 4.1-fold. In
contrast, UCP2 and UCP3L expression was slightly decreased
by these treatments.
UCP mRNA in human skin
The expression of UCP mRNA was evaluated in the epidermis
obtained from human skin, which did not contain dermis,
subcutaneous tissue, or any blood cells (Figure 4). In
epidermis samples from the forearm and abdomen, clear
signals corresponding to UCP2, UCP3L, and UCP3S were
observed. Furthermore, a UCP1 signal was detected in both
epidermal samples. The nucleotide sequence of this
PCR product was completely identical to that of human
UCPs. No mRNA signal for the adipocyte-specific molecule
aP2 or the myoblast-specific molecule myogenin was
detected in these samples. In the commercially available
human skeletal muscle cDNA library, which was examined
as a positive control, strong signals for UCP2 and two
forms of UCP3 were found, but no signal corresponding to
UCP1 was detected. In contrast, in the commercially
available human skin cDNA library, a clear UCP1 signal, as
well as those for UCP2, UCP3L, and UCP3S, was detected
(data not shown).
Immunohistochemistry of human skin and keratinocytes
The localization of UCP1 and UCP3 was studied in sections
of human skin. Weak positive signals for UCP1 were widely
observed in the epidermis, and strong signals were observed
in the granular layer, the epidermal second outer layer
composed of flattened living keratinocytes, and all skin
samples obtained from four volunteers (Figure 5a). Sweat
glands of the forearm, abdomen, and cheek; sebaceous
glands of the cheek; upper thigh and abdomen; and hair
follicles of the cheek were also stained (Figure 5b).
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Figure 1. Expression of UCP1, UCP2, and two forms of UCP3 mRNA in
cultured keratinocytes and fibroblasts derived from human skin. Genomic
DNA, as negative control, was not found at the same size as mRNA. Skeletal
muscle cDNA was used as positive control for UCP2 and UCP3.
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Figure 2. Time course of UCP1, UCP2, and UCP3L mRNA expression during
differentiation of human keratinocytes. (a) UCP signals were shown by
RT-PCR. (b) UCP signals quantified by real-time PCR were normalized to
GAPDH signals. Each value represents the mean±SEM of four incubation
wells. *Po0.05 compared with the value of the control (before high-calcium
condition for differentiation).
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Stronger positive signals for UCP3 were observed in the
epidermis than in the dermis, the major component of which
was fibrous extracellular matrix. Intense staining of the
cytoplasm was noted particularly in the stratum basale of
the epidermis, the major area for active proliferation of
keratinocytes (Figure 6). Furthermore, positive staining was
detected in the sweat glands and epithelium of the hair
follicle (Figure 7).
Expression of UCP1 in incubated human keratinocytes
was also investigated. Intense positive staining of the
cytoplasm was confirmed in most cells. Signals were
dispersed throughout the cytoplasm and absent from the
nucleus.
Localization of UCP1 in the human epidermis and in the
keratinocytes was compared with that of porin, a mitochon-
drial marker (Figure 8). The epidermis and the incubated
keratinocytes were uniformly stained by an anti-porin anti-
body with densely dyed spots. UCP1 was densely localized
in the granular layer and widely in incubated keratinocytes
with condensed spots. These results showed colocalization of
UCP1 with the mitochondrial marker in keratinocytes, and
the former was highly expressed in the granular layer of the
epidermis.
DISCUSSION
In this study, we examined the expression of UCP1, UCP2,
and UCP3 in human skin, including the epidermis and dermis
with accessory organs. While UCP1 has been considered as
being expressed exclusively in BAT, the present RT–PCR
analysis revealed UCP1 expression in a cDNA library of
human skin and cultured keratinocytes, the major component
of the epidermis, but not in a cDNA library of human skeletal
muscle and cultured fibroblasts. UCP1 signals were also
detected in human skin, that is, UCP1 mRNA was detected in
two sites of the human body. The size and nucleotide
sequence of the PCR products were completely identical to
those expected from human UCP1.
Furthermore, we established UCP1 expression at the
protein level and its localization not only in the granular
layer of the epidermis, but also in sweat glands, sebum
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a b
Figure 3. Effects of RA and NE treatments on UCP1, UCP2, and UCP3L mRNA expression. Human keratinocytes were incubated with or without 1 mm NE and/
or 1 mm RA for 24 hours. (a) UCP signals were shown by RT-PCR. (b) UCP signals quantified by real-time PCR were normalized to GAPDH signals. Each value
represents the mean±SEM of four incubation wells. *Po0.05 compared with the value of the control (without RA and NE).
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Figure 4. Expression of UCP1, UCP2, and two forms of UCP3 mRNA in
human epidermis. GAPDH was used as control.
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glands, and hair follicles of various sites. In vitro study
showed high expression of UCP1 in differentiated keratino-
cytes. These results showed significant expression of UCP1 in
human skin, particularly in the epithelium, including
keratinocytes of the epidermis and exocrine glands, and its
upregulation in a differentiated stage.
UCP1 expression in BAT is known to be upregulated by
NE or a b-adrenergic agonist and RA through activation of the
b-adrenergic receptor and retinoid X-receptor, respectively
(Chuong et al., 2002). Similarly, UCP1 mRNA levels in
cultured keratinocytes were increased after stimulation with
NE and RA synergistically, suggesting nutritional and
hormonal mechanisms controlling keratinocyte UCP1 ex-
pression similar to those in BAT. More investigation at the
protein level is necessary, but these results are indirect
evidence suggesting some physiological function under
hormonal control in the skin.
The mRNA expression of UCP2 and UCP3 was detected
not only in the epidermis and skin-derived keratinocytes, but
also in the fibroblasts. While UCP3 expression has been
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Figure 5. Immunohistochemistry for UCP1. (a) UCP1 expression in human epidermis at various sites. The upper left figure is the forearm, upper right is
upper thigh, lower left is abdomen, and lower right is cheek. Arrows show positively stained area (red). E, epidermis; D, dermis; Bar¼100 mm. (b) UCP1
expression in the accessory organs of the skin. The upper left figure is a sweat gland of the forearm, upper right is a sweat gland of abdomen, lower left is a
sebaceous gland of upper thigh, and lower right is a sebaceous gland of cheek. S, sweat gland; Sb, sebaceous gland; F, hair follicle. Bars¼100 and 200 mm
(only in the lower right figures).
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Figure 6. Immunohistochemistry for UCP3. (a) UCP3 expression in human epidermis. Positively stained area is brown. E, epidermis; D, dermis. Bar¼100 mm.
(b) UCP3 expression in the accessory organs of the skin. F, hair follicle; S, sweat gland. Bars¼100 mm.
Figure 7. Immunohistochemistry for UCP1 in human keratinocytes. The left
figure is stained by anti-UCP, and the right figure by control IgG. Positively
stained area is red. Bar¼50 mm.
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considered to be specific to the skeletal muscle, heart, and
adipose tissue, including BAT, the present results revealed
UCP3 expression in human skin at levels comparable to
muscle tissue. In particular, UCP3 protein was detected in the
stratum basale of the epidermis and also in sweat glands and
hair follicles, suggesting UCP3 expression in the epithelium
of the skin, including fibroblasts.
Although the roles of UCPs in the skin are not known, it
seems interesting that UCP2 might have the ability to modify
the production of reactive oxygen species. In this regard, skin
is frequently exposed to various chemical, physical, and
biological stresses, such as microbial infection, ultraviolet
ray, and temperature change, which accelerate the secretion
and peroxidation of sebum lipid and protein degeneration
with the inflammatory process or immune response. Since
reactive oxygen species are produced in these protective
processes, UCP2 in the skin may be involved in regulating the
production of skin reactive oxygen species, being controlled
via the b-adrenergic receptor and retinoid receptor (Solanki
and Murray, 1978, 1982; Schallreuter et al., 1992; Mao-
Qiang et al., 2004; Schmuth et al., 2004).
There are various reports about non-adipose UCP1
expression in the rodent brain at the protein level and in
the thymus at the mRNA level, but the latter is controversial
(Carroll et al., 2004, 2005; Lengacher et al., 2004). Our
report includes the first findings of human UCP1 at the mRNA
level and protein level in non-adipose tissues. Considering
the significant role of UCP1 in BAT for metabolic thermo-
genesis, UCP1 in human skin may also be involved in
thermoregulation in the skin. Analytical methods to detect
UCPs should be established. Alternatively, UCP1, as well as
UCP2, may participate in the protective function against
oxidative stress in the skin. Further studies are needed to
make these intriguing ideas more convincing.
MATERIALS AND METHODS
Cell culture
Human keratinocytes (NHEK-B) and fibroblasts (NHDF-NB) were
obtained from KURABO (Osaka, Japan) and cultured individually in
a proliferation medium (HuMedia-KG2; KURABO) or DMEM at
37 1C in a 5% CO2 atmosphere until confluence, the medium being
renewed twice a week. In the first mRNA analysis experiment, cells
were collected and total RNA was extracted with Isogen (Nippon
Gene Co. Ltd, Tokyo, Japan). In the second experiment, keratino-
cytes were differentiated in the presence of a high concentration of
calcium under an air–liquid boundary condition. Briefly, keratino-
cytes from fetal foreskin were seeded on the inserts with a collagen
type I-coated semi-permeable membrane (Biocoat Cell Culture
Inserts; BD Biosciences, San Jose, CA) in a differentiation medium
(mixture of DMEM and Ham’s F-12 medium with 10% fetal calf
serum, 10 mgml1 insulin, 1mM hydrocortisone, 0.3mM L-ascorbic
acid, and 1.3mM calcium chloride). The next day, the medium on
the membrane was removed and its upper surface was exposed to
air. On the first day and every two days, cells were collected and
total RNA was extracted in the same manner. In the third
experiment, keratinocytes were cultured until confluence in the
proliferation medium and treated with 1 mM RA (Sigma, St Louis, MO)
and/or 1 mM NE (Sigma) for 24 hours. Four incubation wells were
used for each condition, and total RNA was extracted in the same
manner.
For immunohistochemical analysis, proliferated keratinocytes
were washed with phosphate-buffered saline and collected into 4%
paraformaldehyde phosphate-buffered solution.
Human skin samples
Human epidermis was obtained from the forearm and abdomen of a
healthy male volunteer (age 40 years) using a suction blister. The
tissues were immediately washed with phosphate-buffered saline
and stored in Isogen for RNA extraction. Tissue specimens (5mm in
diameter) for immunohistochemical analysis were also punched out
of the forearm, upper thigh, abdomen, and cheek of four volunteers
(ages 6069 years). These tissue samples were immediately frozen
in liquid nitrogen.
The design and performance of skin sampling was in agreement
with the Declaration of Helsinki Principles. All subjects gave written
and informed consent. The study was approved by the Ethics
Committee at Kao Corporation.
RNA extraction and RT–PCR analysis
Total RNA was extracted with guanidine-isothiocyanate using Isogen
with proteinase K and DNase I treatment (Qiagen, Hilden, Germany)
according to the manufacturer’s instructions. The mRNA of each
UCP subtype was analyzed with RT–PCR. Briefly, cDNA was
synthesized from total RNA (5–50 ng) using TaqMan Reverse
Transcription Reagents (Applied Biosystems Japan, Tokyo, Japan)
and amplified using a PCR SuperMIX or AccuPrime PCR SuperMIX
(Invitrogen, Carlsbad, CA) with individual gene-specific primer sets
(Table 1), according to the manufacturer’s instructions. The number
of cycles for PCR was 25 for glyceraldehyde-3-phosphate dehy-
drogenase (GAPDH) as an internal standard and 35 for UCP1, UCP2,
a b c d
Figure 8. Immunohistochemical analysis of porin expression compared with UCP1 in human epidermis and incubated keratinocytes. (a and b) Epidermis;
(c and d) keratinocytes. The left figures are stained by anti-porin, and the right figures by anti-UCP1. Positively stained area is red. Bar¼ 10 mm.
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and UCP3 (UCP3L and UCP3S) in human skin samples. In cell
samples, it was 25 for GAPDH, 35 for UCP1, 25 for UCP2, and 30
for UCP3. Human genomic DNA (Clontech, Mountain View, CA),
human skeletal muscle DNA (Biochain Institute, Hayward, CA), and
human skin cDNA (Biochain Institute) were also analyzed.
RT–PCR products were electrophoresed in agarose gel and
analyzed by Molecular Imager FX (Bio-Rad Laboratories, Inc.,
Tokyo, Japan). Some electrophoresed bands were extracted from
agarose gel using silica particles of QIAEX II (Qiagen), purified with
glass powder, and sequenced with forward primers and reverse
primers using an ABI Prism 377 DNA sequencer (Applied Biosystems
Biosystems Japan, Tokyo, Japan).
Furthermore, cDNA samples from keratinocytes were analyzed
by real-time PCR with a TaqMan PCR kit (Applied Biosystems Japan)
using an ABI Prism 7700 (Applied Biosystems Japan) according to
the manufacturer’s instructions. Sequences of primer sets and
fluorescence-labeled probes for real-time PCR in this investigation
are shown in Table 2. Quantitative data were analyzed by analysis of
variance, followed by Bonferroni’s method for multiple comparisons
between pairs.
Immunohistochemical analysis
Tissue specimens obtained from the skin were fixed with 10%
formalin, paraffin embedded, sectioned (5 mm thick), and exposed to
Table 1. Primer sets for RT–PCR for UCP1, UCP2, UCP3, and GAPDH
Target gene GenBank Accession No. Amplicon size (bp) Primer Sequence1
Human UCP1 NM021833 134 f2 TCTCTCAGGATCGGCCTCTA
r3 GTGGGTTGCCCAATGAATAC
Human UCP2 NM003355 538 f CATTCTGACCATGGTGCGTACTGA
r GTTCATGTATCTCGTCTTGACCAC
Human UCP3L U84763 263 f CTCCAGGCCAGTACTTCAGC
r GATGCACCGTTTTCTTCC
Human UCP3S U82818 321 f AAGGAGAAGCTGCTGGACTA
r TGTACTCTTCACCGCTACATCC
Human GAPDH J04038 226 f GAAGGTGAAGGTCGGAGTC
r GAAGATGGTGATGGGATTTC
GAPDH, glyceraldehyde-3-phosphate dehydrogenase; RT–PCR, reverse transcriptase–PCR; UCP, uncoupling protein.
1Nucleotide sequences are shown from 50-end to 30-end.
2Front primer.
3Reverse primer.
Table 2. Primer sets and probes for real-time PCR for UCP1, UCP2, UCP3, and GAPDH
Target gene GenBank Accession No. Amplicon size (bp) Primer Sequence1
Human UCP1 NM021833 77 f2 GCCTTTGTGAAAAACAACATATTAGC
r3 GCGCAAAATCCAGCGATAA
p4 TGTCGTCCCCTGCCACTTGGTG
Human UCP2 NM003355 71 f CCTCCTGAAAGCCAACCTCA
r AGAAGCCTGCCCCAAAGG
p ACAGATGACCTCCCTTGTCACTTCACTTCT
Human UCP3L U84763 189 f CACAGCCTTCTACAAGGGATTTACAC
r CTTCCATTCTTAACTGGTTTCGGA
p ACCTATGAGCAGCTGAAACGGGCCCT
Human GAPDH J04038 226 f GAAGGTGAAGGTCGGAGTC
r GAAGATGGTGATGGGATTTC
p CAAGCTTCCCGTTCTCAGCC
GAPDH, glyceraldehyde-3-phosphate dehydrogenase; UCP, uncoupling protein.
1Nucleotide sequences are shown from 50-end to 30-end.
2Front primer
3Reverse primer.
4Probe.
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a rabbit anti-human UCP1 antibody (No. ab10983; Abcam, Cam-
bridge, UK), UCP3 antibody (No. UCP32-A; Alpha Diagnostic
International, San Antonio, TX), or non-immune rabbit IgG
(Chemicon International, Temecula, CA). The UCP1 antibody
recognizes epitope mapping near the N-terminal of human UCP1,
and the UCP3 antibody recognizes that near the C-terminal of the
long and mature form of human UCP3L. Briefly, following treatment
with target unmasking fluid (Sanbio BV, Am Uden, Netherlands) for
10minutes at 90 1C, or with a microwave for 10minutes at 120 1C,
sections were treated with 0.3% hydrogen peroxide solution for
30minutes at room temperature, dehydrated, blocked with 3%
skimmed milk in phosphate-buffered saline for 120minutes, and
then exposed to primary antibodies (2 mgml1 for UCP1 and
20 mgml1 for UCP3) or control IgG (same concentration to primary
antibody) for 120minutes at 4 1C. Bound antibody was visualized by
a horseradish peroxidase-labeled anti-rabbit IgG kit (Nichirei,
Tokyo, Japan) with diaminobenzidine or amino ethyl carbazole,
followed by counterstaining with hematoxylin.
Human keratinocytes (NHEK-B) fixed with 4% paraformaldehyde
phosphate-buffered solution were paraffin embedded, sectioned
(34 mm thick), exposed to a rabbit anti-human UCP1 antibody, and
visualized similar to the methods for the tissue sections.
To confirm localization of UCP in mitochondria, the same
immunohistochemical staining was performed using the antibody for
porin (No. ab15895; Abcam).
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